Abstract
In head and neck cancers brachytherapy can be used either as definitive modality in early cancers or as boost in patients with larger tumors. Brachytherapy delivers higher biologically equivalent compared to EBRT, but disadvantages are its inability to treat nodes and invasive procedure. Proper patient selection is the key to any successful head and neck brachytherapy protocol. The chapter describes indications, contraindications, pretreatment evaluation, procedure, target delineation, and plan evaluation in head and neck brachytherapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Quon H, Harrison LB. Brachytherapy in the treatment of head and neck cancer. Oncology (Williston Park). 2002;16(10):1379–96.
Kovács G, Martinez-Monge R, Budrukkar A, Guinot JL, Johansson B, Strnad V, et al. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update: improvement by cross sectional imaging based treatment planning and stepping source technology. Radiother Oncol. 2017;122(2):248–54.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Mallick, S., Rath, G.K. (2020). Brachytherapy in Head and Neck Cancers. In: Mallick, S., Rath, G., Benson, R. (eds) Practical Radiation Oncology. Springer, Singapore. https://doi.org/10.1007/978-981-15-0073-2_18
Download citation
DOI: https://doi.org/10.1007/978-981-15-0073-2_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0072-5
Online ISBN: 978-981-15-0073-2
eBook Packages: MedicineMedicine (R0)